Individuals with the highest risk for adverse outcomes of COVID-19 should be prioritized by the vaccine allocation policies. We have conducted a literature review of published studies, which comprehend congenital heart disease (CHD) and COVID-19, in order to present the overall evidences of both exposure and clinical risk of patients with adult congenital heart disease (ACHD) and to propose a risk profile schema for those patients to be incorporated into vaccine distribution decisions.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8206548 | PMC |
| http://dx.doi.org/10.1016/j.ijcchd.2021.100186 | DOI Listing |
Publication Analysis
Top Keywords
congenital heart
12
heart disease
12
adult congenital
8
disease special
4
special considerations
4
considerations covid-19
4
covid-19 vaccine
4
vaccine allocation/prioritization
4
allocation/prioritization individuals
4
individuals highest
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!